Dioxin increases the interaction between aryl hydrocarbon receptor and estrogen receptor alpha at human promoters

Toxicological Sciences

Volumn 111, Issue 2, 2009, Pages 254-266

  Ahmed, Shaimaa ^a   Valen, Eivind ^b   Sandelin, Albin ^b   Matthews, Jason ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Aryl hydrocarbon receptor; ChIP chip; Dioxin; Estrogen receptor ; Receptor crosstalk

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CYCLIN G2; CYCLINE; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; ESTROGEN RECEPTOR ALPHA; HOMEODOMAIN PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; MESSENGER RNA; PROSPERO HOMEOBOX 1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENETIC REGULATION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PROMOTER REGION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

BASE SEQUENCE; BLOTTING, WESTERN; DIOXINS; DNA PRIMERS; ESTROGEN RECEPTOR ALPHA; HUMANS; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; RECEPTORS, ARYL HYDROCARBON;

EID: 70349288025     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfp144     Document Type: Article

References (67)

1. Angus, W. G., Larsen, M. C., and Jefcoate, C. R. (1999). Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: Role of estrogen receptor status. Carcinogenesis 20, 947-955.
2. Boverhof, D. R., Burgoon, L. D., Williams, K. J., and Zacharewski, T. R. (2008). Inhibition of estrogen-mediated uterine gene expression responses by dioxin. Mol. Pharmacol. 73, 82-93.
3. Bryne, J. C., Valen, E., Tang, M. H., Marstrand, T., Winther, O., da Piedade, I., Krogh, A., Lenhard, B., and Sandelin, A. (2008). JASPAR, the open access database of transcription factor-binding profiles: New content and tools in the 2008 update. Nucleic Acids Res. 36, D102-D106.
4. Carroll, J. S., Liu, X. S., Brodsky, A. S., Li, W., Meyer, C. A., Szary, A. J., Eeckhoute, J., Shao, W., Hestermann, E. V., Geistlinger, T. R., et al. (2005). Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122, 33-43.
5. Carroll, J. S., Meyer, C. A., Song, J., Li, W., Geistlinger, T. R., Eeckhoute, J., Brodsky, A. S., Keeton, E. K., Fertuck, K. C., Hall, G. F., et al. (2006). Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 38, 1289-1297.
6. Castles, C. G., Oesterreich, S., Hansen, R., and Fuqua, S. A. (1997). Auto-regulation of the estrogen receptor promoter. J. Steroid. Biochem. Mol. Biol. 62, 155-163.
7. DeNardo, D. G., Kim, H. T., Hilsenbeck, S., Cuba, V., Tsimelzon, A., and Brown, P. H. (2005). Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: Identification of estrogen-induced/activator protein-1-dependent genes. Mol. Endocrinol. 19, 362-378.
8. Denison, M. S., and Nagy, S. R. (2003). Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43, 309-334.
9. Finlin, B. S., Gau, C. L., Murphy, G. A., Shao, H., Kimel, T., Seitz, R. S., Chiu, Y. F., Botstein, D., Brown, P. O., Der, C. J., et al. (2001). RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer. J. Biol. Chem. 276, 42259-42267.
10. Flicek, P., Aken, B. L., Beal, K., Ballester, B., Caccamo, M., Chen, Y., Clarke, L., Coates, G., Cunningham, F., Cutts, T., et al. (2008). Ensembl 2008. Nucleic Acids Res. 36, D707-D714.
11. Frasor, J., Stossi, F., Danes, J. M., Komm, B., Lyttle, C. R., and Katzenellenbogen, B. S. (2004). Selective estrogen receptor modulators: Discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells. Cancer Res. 64, 1522-1533.
12. Gillesby, B. E., Stanostefano, M., Porter, W., Safe, S., Wu, Z. F., and Zacharewski, T. R. (1997). Identification of a motif within the 5' regulatory region of pS2 which is responsible for AP-1 binding and TCDD-mediated suppression. Biochemistry 36, 6080-6089.
13. Hankinson, O. (1995). The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35, 307-340.
14. Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., Tujague, M., Strom, A., Treuter, E., Warner, M., et al. (2007). Estrogen receptors: How do they signal and what are their targets. Physiol. Rev. 87, 905-931.
15. Ihaka, R., and Gentleman, R. (1996). R: A language for data analysis and graphics. J. Comput. Graph. Stat. 5, 299-314.
16. Ji, H., Jiang, H., Ma, W., Johnson, D. S., Myers, R. M., and Wong, W. H. (2008). An integrated software system for analyzing ChIP-chip and ChIP-seq data. Nat. Biotechnol. 26, 1293-1300.
17. Ji, H., and Wong, W. H. (2005). TileMap: Create chromosomal map of tiling array hybridizations. Bioinformatics 21, 3629-3636.
18. John, S., Sabo, P. J., Johnson, T. A., Sung, M. H., Biddie, S. C., Lightman, S. L., Voss, T. C., Davis, S. R., Meltzer, P. S., Stamatoyannopoulos, J. A., et al. (2008). Interaction of the glucocorticoid receptor with the chromatin landscape. Mol. Cell. 29, 611-624.
19. Karolchik, D., Kuhn, R. M., Baertsch, R., Barber, G. P., Clawson, H., Diekhans, M., Giardine, B., Harte, R. A., Hinrichs, A. S., Hsu, F., et al. (2008). The UCSC Genome Browser Database: 2008 update. Nucleic Acids Res. 36, D773-D779.
20. Kinehara, M., Fukuda, I., Yoshida, K., and Ashida, H. (2008). High-throughput evaluation of aryl hydrocarbon receptor-binding sites selected via chromatin immunoprecipitation-based screening in Hepa-1c1c7 cells stimulated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Genes Genet. Syst. 83, 455-468.
21. Kininis, M., Chen, B. S., Diehl, A. G., Isaacs, G. D., Zhang, T., Siepel, A. C., Clark, A. G., and Kraus, W. L. (2007). Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters. Mol. Cell. Biol. 27, 5090-5104.
22. Kirkwood, K. L., Homick, K., Dragon, M. B., and Bradford, P. G. (1997). Cloning and characterization of the type I inositol 1,4,5-trisphosphate receptor gene promoter. Regulation by 17beta-estradiol in osteoblasts. J. Biol. Chem. 272, 22425-22431.
23. Klinge, C. M., Bowers, J. L., Kulakosky, P. C., Kamboj, K. K., and Swanson, H. I. (1999). The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements. Mol. Cell. Endocrinol. 157, 105-119.
24. Kobayashi, A., Sogawa, K., and Fujii-Kuriyama, Y. (1996). Cooperative interaction between AhR.Arnt and Sp1 for the drug-inducible expression of CYP1A1 gene. J. Biol. Chem. 271, 12310-12316.
25. Krum, S. A., Miranda-Carboni, G. A., Lupien, M., Eeckhoute, J., Carroll, J. S., and Brown, M. (2008). Unique ERalpha cistromes control cell type-specific gene regulation. Mol. Endocrinol. 22, 2393-2406.
26. Kwon, Y. S., Garcia-Bassets, I., Hutt, K. R., Cheng, C. S., Jin, M., Liu, D., Benner, C., Wang, D., Ye, Z., Bibikova, M., et al. (2007). Sensitive ChIPDSL technology reveals an extensive estrogen receptor alpha-binding program on human gene promoters. Proc. Natl. Acad. Sci. U. S. A. 104, 4852-4857.
27. Laganiere, J., Deblois, G., Lefebvre, C., Bataille, A. R., Robert, F., and Giguere, V. (2005). From the cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc. Natl. Acad. Sci. U. S. A. 102, 11651-11656.
28. Lin, C. Y., Strom, A., Vega, V. B., Kong, S. L., Yeo, A. L., Thomsen, J. S., Chan, W. C., Doray, B., Bangarusamy, D. K., Ramasamy, A., et al. (2004). Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells. Genome. Biol. 5, R66.
29. Lin, C. Y., Vega, V. B., Thomsen, J. S., Zhang, T., Kong, S. L., Xie, M., Chiu, K. P., Lipovich, L., Barnett, D. H., Stossi, F., et al. (2007). Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet. 3, e87.
30. Liu, Y., Gao, H., Marstrand, T. T., Strom, A., Valen, E., Sandelin, A., Gustafsson, J. A., and Dahlman-Wright, K. (2008). The genome landscape of ERalpha- and ERbeta-binding DNA regions. Proc. Natl. Acad. Sci. U. S. A. 105, 2604-2609.
31. Marstrand, T. T., Frellsen, J., Moltke, I., Thiim, M., Valen, E., Retelska, D., and Krogh, A. (2008). Asap: A framework for over-representation statistics for transcription factor binding sites. PLoS ONE 3, e1623.
32. Matthews, J., and Gustafsson, J. A. (2006). Estrogen receptor and aryl hydrocarbon receptor signaling pathways. Nucl. Recept. Signal 4 e016.
33. Matthews, J., Wihlen, B., Heldring, N., MacPherson, L., Helguero, L., Treuter, E., Haldosen, L. A., and Gustafsson, J. A. (2007). Co-planar 3,3′,4,4′,5-pentachlorinated biphenyl and non-co-planar 2,2′,4,6,6′-pentachlorinated biphenyl differentially induce recruitment of oestrogen receptor alpha to aryl hydrocarbon receptor target genes. Biochem. J. 406, 343-353.
34. Matthews, J., Wihlen, B., Thomsen, J., and Gustafsson, J. A. (2005). Aryl hydrocarbon receptor-mediated transcription: Ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters. Mol. Cell. Biol. 25, 5317-5328.
35. Matthews, J., Wihlen, B., Tujague, M., Wan, J., Strom, A., and Gustafsson, J. A. (2006). Estrogen receptor (ER) beta modulates ERalphamediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters. Mol. Endocrinol. 20, 534-543.
36. McLachlan, J. A., Simpson, E., and Martin, M. (2006). Endocrine disrupters and female reproductive health. Best Pract. Res. Clin. Endocrinol. Metab. 20, 63-75.
37. Nebert, D. W., Dalton, T. P., Okey, A. B., and Gonzalez, F. J. (2004). Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 279, 23847-23850.
38. Nilsson, S., and Gustafsson, J. A. (2000). Estrogen receptor transcription and transactivation: Basic aspects of estrogen action. Breast Cancer Res. 2, 360-366.
39. Nilsson, S., Makela, S., Treuter, E., Tujague, M., Thomsen, J., Andersson, G., Enmark, E., Pettersson, K., Warner, M., and Gustafsson, J. A. (2001). Mechanisms of estrogen action. Physiol. Rev. 81 1535-1565.
40. Ohtake, F., Baba, A., Takada, I., Okada, M., Iwasaki, K., Miki, H., Takahashi, S., Kouzmenko, A., Nohara, K., Chiba, T., et al. (2007). Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature 446, 562-566.
41. Okey, A. B. (2007). An aryl hydrocarbon receptor odyssey to the shores of toxicology: The Deichmann Lecture, International Congress of ToxicologyXI. Toxicol. Sci. 98, 5-38.
42. Okino, S. T., Quattrochi, L. C., Pookot, D., Iwahashi, M., and Dahiya, R. (2007). A dioxin-responsive enhancer 3' of the human CYP1A2 gene. Mol. Pharmacol. 72, 1457-1465.
43. Paech, K., Webb, P., Kuiper, G. G., Nilsson, S., Gustafsson, J., Kushner, P. J., and Scanlan, T. S. (1997). Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277, 1508-1510.
44. Petrulis, J. R., and Perdew, G. H. (2002). The role of chaperone proteins in the aryl hydrocarbon receptor core complex. Chem. Biol. Interact. 141, 25-40.
45. Puga, A., Maier, A., and Medvedovic, M. (2000). The transcriptional signature of dioxin in human hepatoma HepG2 cells. Biochem. Pharmacol. 60, 1129-1142.
46. Puga, A., Marlowe, J., Barnes, S., Chang, C. Y., Maier, A., Tan, Z., Kerzee, J. K., Chang, X., Strobeck, M., and Knudsen, E. S. (2002). Role of the aryl hydrocarbon receptor in cell cycle regulation. Toxicology 181-182, 171-177.
47. Safe, S. (1993). Toxicology, structure-function relationship, and human and environmental health impacts of polychlorinated biphenyls: Progress and problems. Environ. Health Perspect. 100, 259-268.
48. Safe, S., Wang, F., Porter, W., Duan, R., and McDougal, A. (1998). Ah receptor agonists as endocrine disruptors: Antiestrogenic activity and mechanisms. Toxicol. Lett. 102-103, 343-347.
49. Safe, S., and Wormke, M. (2003). Inhibitory aryl hydrocarbon receptorestrogen receptor alpha cross-talk and mechanisms of action. Chem. Res. Toxicol. 16, 807-816.
50. Sartor, M. A., Schnekenburger, M., Marlowe, J. L., Reichard, J. F., Wang, Y., Fan, Y., Ma, C., Karyala, S., Halbleib, D., Liu, X., et al. (2009). Functional and physical interactions between the estrogen receptor Sp1 and nuclear aryl hydrocarbon receptor complexes. Environ. Health Perspect. 117, 1139-1146.
51. Saville, B., Wormke, M., Wang, F., Nguyen, T., Enmark, E., Kuiper, G., Gustafsson, J. A., and Safe, S. (2000). Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J. Biol. Chem. 275, 5379-5387.
52. Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A., and Brown, M. (2000). Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103, 843-852.
53. So, A. Y., Chaivorapol, C., Bolton, E. C., Li, H., and Yamamoto, K. R. (2007). Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet. 3, e94.
54. Stossi, F., Likhite, V. S., Katzenellenbogen, J. A., and Katzenellenbogen, B. S. (2006). Estrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a repressor complex at the cyclin G2 promoter. J. Biol. Chem. 281, 16272-16278.
55. Tan, Z., Huang, M., Puga, A., and Xia, Y. (2004). A critical role for MAP kinases in the control of Ah receptor complex activity. Toxicol. Sci. 82, 80-87.
56. Tian, Y., Ke, S., Denison, M. S., Rabson, A. B., and Gallo, M. A. (1999). Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity. J. Biol. Chem. 274, 510-515.
57. Tian, Y., Ke, S., Thomas, T., Meeker, R. J., and Gallo, M. A. (1998). Transcriptional suppression of estrogen receptor gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). J. Steroid. Biochem. Mol. Biol. 67, 17-24.
58. Tian, Y., Rabson, A. B., and Gallo, M. A. (2002). Ah receptor and NF-kappaB interactions: Mechanisms and physiological implications. Chem. Biol. Interact. 141, 97-115.
59. Tsuchiya, Y., Nakajima, M., Kyo, S., Kanaya, T., Inoue, M., and Yokoi, T. (2004). Human CYP1B1 is regulated by estradiol via estrogen receptor. Cancer Res. 64, 3119-3125.
60. Wang, F., Hoivik, D., Pollenz, R., and Safe, S. (1998). Functional and physical interactions between the estrogen receptor Sp1 and nuclear aryl hydrocarbon receptor complexes. Nucleic Acids Res. 26, 3044-3052.
61. Wang, F., Samudio, I., and Safe, S. (2001). Transcriptional activation of cathepsin D gene expression by 17beta-estradiol: Mechanism of aryl hydrocarbon receptor-mediated inhibition. Mol. Cell. Endocrinol. 172, 91-103.
62. Wasserman, W. W., and Sandelin, A. (2004). Applied bioinformatics for the identification of regulatory elements. Nat. Rev. Genet. 5 276-287.
63. Whitlock, J. P., Jr. (1999). Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 39, 103-125.
64. Wihlen, B., Ahmed, S., Inzunza, J., and Matthews, J. (2009). Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptordependent transcription. Mol. Cancer Res. 7, 977-986.
65. Wormke, M., Stoner, M., Saville, B., Walker, K., Abdelrahim, M., Burghardt, R., and Safe, S. (2003). The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes. Mol. Cell. Biol. 23, 1843-1855.
66. Yang, X., Solomon, S., Fraser, L. R., Trombino, A. F., Liu, D., Sonenshein, G. E., Hestermann, E. V., and Sherr, D. H. (2008). Constitutive regulation of CYP1B1 by the aryl hydrocarbon receptor (AhR) in pre-malignant and malignant mammary tissue. J. Cell. Biochem. 104, 402-417.
67. Zhou, Y., Eppenberger-Castori, S., Eppenberger, U., and Benz, C. C. (2005). The NFkappaB pathway and endocrine-resistant breast cancer. Endocr. Relat. Cancer 12(Suppl. 1), S37-S46.